Non-surgical Alternatives to Treatment of Failed Medical Abortion

• Status: Terminated
• Trial end date: 2019-01-16
• Target enrollment: 0
• Participant gender: Female

Summary

The primary outcome of this study is to compare the effectiveness of a second complete course of 200 mg mifepristone and 800 mcg misoprostol for ongoing pregnancy following mifepristone-misoprostol medical abortion.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Gynuity Health Projects
• Treatments: Mifepristone; Misoprostol

Criteria

Inclusion Criteria:

• Have ultrasound evidence of an ongoing pregnancy (embryo with cardiac activity) <= 77 days gestational age at follow-up after using a mifepristone-misoprostol regimen for termination of pregnancy

• Agree to comply with study procedures

• Able to consent to study participation

Exclusion Criteria:

• Have an ongoing pregnancy but did not take an initial course of mifepristone and misoprostol at the study site

• Are < 18 years old in US and Canadian sites

• Present with other medical abortion outcomes including persistent non-viable pregnancies or empty sac

• Are unable to provide contact information for follow-up purposes